Conserve PCR reagents and improve scalability with precision liquid handling
14 Aug 2025
BioDot’s precision liquid dispensing platforms are shaping the future of discovery. In this SelectScience interview, Thomas Winter, Manager of Sales, Life Sciences & OEM, BioDot, explains how BioDot enables cutting-edge work in PCR, sequencing, direct titration, and other high-value life science workflows. Hear how the systems like Omnia™, Omnia™ Discovery, and the new Omnia™ Versa support accuracy, flexibility, and miniaturization across R&D environments.
SelectScience interview filmed at ADLM 2025.
About the company
BioDot Inc.
BioDot aims to become the principle supplier of sub-microliter dispense systems (for the manufacture of micro-array and microfluidic devices) to Molecular Diagnostics, Theranostics and other emerging markets. This is driven by on-going technology development programs delivering Dispensing Innovation products like BioJet Plus. This unique non-contact nanoliter dispenser delivers genuine on the fly deposition of small drop volumes for high throughput production of Biosensors, BioChips and Protein/Cell arrays.
BioDot is already established as world leader in the supply of equipment and technology for the development and manufacture of membrane Rapid Diagnostic Tests and Biosensors.
BioDot enables, inspires, and educates scientists to commercialize their ideas from R&D through to manufactured product.
Related products
Request Quote for All Products
Omnia™
BioDot Inc.Discrete Picoliter, Nanoliter, and Microliter drops with unmatched speed and precision by combining proprietary Rainmaker™ and BioJet™ dispensing technologies on one platform.
